Cover Image

Innovations in pharmacovigilance studies of medicines in older people

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Lisa M. Kalisch Ellett, Jack L. Janetzki, Renly Lim, Tracey‐Lea Laba, Nicole L. Pratt
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	British Journal of Clinical Pharmacology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Section 19A in practice: Assessing the provision of overseas‐registered medicines to mitigate the impact of medicine shortages in Australia
by: Jack Janetzki, et al.
Published: (2025)

Economic evaluations of therapeutic drug monitoring interventions in acute hospital‐based settings: A systematic review
by: Jane E. Carland, et al.
Published: (2024)

A scoping review of disease‐modifying antirheumatic drug nonadherence in rheumatoid arthritis: Measurement, prevalence and implications for clinical practice
by: Lauren Fraser, et al.
Published: (2025)

Thirst and drugs: A study in the World Health Organization's pharmacovigilance database
by: Jean‐Louis Montastruc
Published: (2024)

Optimizing real‐world evidence studies for regulatory decision‐making and impact assessment in pharmacovigilance
by: Ignatios Ioakeim‐Skoufa, et al.
Published: (2025)

Incorporating the One Health Philosophy into pharmacovigilance: Ecopharmacovigilance
by: Montserrat García, et al.
Published: (2024)

Potential for use of Al/machine learning for pharmacovigilance: Is there a role for regulators?
by: Christina Gao, et al.
Published: (2025)

Exploring Definity‐related adverse reaction: A real‐world pharmacovigilance study via FAERS database analysis
by: Wenrong Lin, et al.
Published: (2025)

Utilization and expenditure on medicines for the management of osteoporosis in Ireland: A repeated cross‐sectional study
by: Amelia Smith, et al.
Published: (2025)

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System
by: Guanghan Sun, et al.
Published: (2025)

Bleeding in patients on concurrent treatment with serotonin reuptake inhibitor (SRI) and acetylsalicylic acid (ASA) compared with ASA alone: a pharmacovigilance study
by: Jean‐Louis Montastruc, et al.
Published: (2024)

Adverse reactions associated with nivolumab and small molecule antiangiogenic drugs: A pharmacovigilance analysis
by: Haiyang Li, et al.
Published: (2024)

Analysis of interstitial lung disease in pharmacovigilance databases: Coding challenges and interpretation biases—An update
by: Romane Freppel, et al.
Published: (2026)

Drug safety signals in breastfeeding: Bridging evidence from European and US pharmacovigilance systems
by: Hülya Tezel Yalçın, et al.
Published: (2025)

An artificial intelligence algorithm for co‐clustering to help in pharmacovigilance before and during the COVID‐19 pandemic
by: Alexandre Destere, et al.
Published: (2024)

The clinical toxicity of advanced therapy medicinal products
by: Fraser J. H. Henderson, et al.
Published: (2025)

Low‐dose amitriptyline: A potential therapeutic option for chronic pain in older people
by: Takayuki Suga, et al.
Published: (2024)

Equity and quality use of medicines in people who present to the Psychiatric Alcohol and Non‐Prescription Drug Assessment Unit
by: Jana Stojanova, et al.
Published: (2025)

The effect of deprescribing interventions on mortality and health outcomes in older people: An updated systematic review and meta‐analysis
by: Hui Wen Quek, et al.
Published: (2024)

Assessment of clinical pharmacology and competence during medicine clerkships
by: Nicole C. Cheung, et al.
Published: (2025)

A multidisciplinary meeting for generating a personalized pharmaceutical plan for older adults at hospital discharge: the IATROPREV study
by: Chloé Cornille, et al.
Published: (2025)

Co‐prescription of low‐dose methotrexate and trimethoprim‐sulfamethoxazole and the 30‐day risk of death among older adults: A cohort study
by: Hasti Sadeghi, et al.
Published: (2024)

Clinical pharmacology in adolescent transgender medicine
by: Lauren R. Cirrincione, et al.
Published: (2024)

Co‐design–related approaches in medication safety for people with dementia: A scoping review
by: Zena El‐kadomi, et al.
Published: (2026)

Patient preferences and attitudes regarding the environmental impact of medicines: A discrete choice experiment
by: Milad Sadreghaemy, et al.
Published: (2025)

The safety profile of usage of glucagon‐like peptide‐1 receptor agonists in pregnancy: A pharmacovigilance analysis based on the Food and Drug Administration Adverse Event Reporting System
by: Jianxing Zhou, et al.
Published: (2024)

Effects of age, sex, daily dose, comorbidity and co‐medication on venlafaxine‐associated cardiovascular adverse events: A pharmacovigilance analysis of the FDA Adverse Event Reporting System database
by: Zhanzhang Wang, et al.
Published: (2024)

Precision medicine in paediatrics: Progress and priorities
by: Nicola Husain, et al.
Published: (2026)

The prevalence of polypharmacy in older Europeans: A multi‐national database study of general practitioner prescribing
by: Marion Bennie, et al.
Published: (2024)

Consideration of ethnic differences in approvals for anti‐HIV medicines in Japan: Evaluation based on pharmacokinetic studies and post‐marketing data
by: Rumiko Shimazawa, et al.
Published: (2025)

Trust first, concerns second: An international vignette study of older adults' preferences towards deprescribing statins
by: Sarah E. Vordenberg, et al.
Published: (2026)

Deprescribing drugs with anticholinergic effects in older patients with increased risk of dementia in the multicomponent intervention study AgeWell.de
by: Laura K. Lepenies, et al.
Published: (2025)

Correction to “Evaluating the impact of general practice pharmacist‐led person‐centred medicines reviews on medicines appropriateness and patient‐reported outcome measures”
Published: (2026)

Morbimortality consequences of use and misuse of psychoactive medicines in Portugal
by: Ana Carmona Araújo, et al.
Published: (2025)

Sustainable medicines development and use: Challenges and opportunities in the sustainable production of active pharmaceutical ingredients
by: Gary M. Noonan, et al.
Published: (2024)

Incidence of new fractures in older patients with osteoporosis receiving biosimilar teriparatide or reference products: A retrospective cohort study
by: So Sato, et al.
Published: (2024)

Clinical outcomes of switching to dolutegravir/lamivudine dual therapy in people living with HIV: A single‐centre retrospective study
by: D. Yagci‐Caglayik, et al.
Published: (2025)

Moving forward to ‘put people first’
by: Alice Tseng, et al.
Published: (2024)

Analysis of longitudinal patterns and predictors of medicine use in residential aged care using group‐based trajectory modelling: The MEDTRAC‐Polypharmacy longitudinal cohort study
by: Nasir Wabe, et al.
Published: (2024)

A review on the role of extrapolation as basis for paediatric marketing authorization applications of medicines in the EU
by: Charlotte W. M. Simons, et al.
Published: (2025)